ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000259275.1	Ponatinib	Bladder urothelial carcinoma	0.016084698	Sensitive
ENSG00000259275.1	Ponatinib	Breast invasive carcinoma	0.011171158	Sensitive